EXELA
Live / Registered — Registered and renewed (as of 16 Sept 2025)
What this means for you
Registered since 19 May 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 May 2025).
Record
- Serial number
- 85971452
- Registration number
- 4739675
- Mark type
- Stylized text
- Filed
- 27 Jun 2013
- Published for opposition
- 19 Nov 2013
- Registered
- 19 May 2015
- Next maintenance due
- 19 May 2025
- Attorney of record
- Alisa C. Simmons
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, * excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer *
Owner
- Exela Holdings, Inc., Lenoir, NC, US
- Exela Holdings, Inc., Lenoir, NC, US
- Exela Holdings, Inc., Lenoir, NC, US
Prior registrations
Prosecution history
- 16 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 16 Sept 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 16 Sept 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Sept 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 May 2025 — TEAS SECTION 8 & 9 RECEIVED
- 19 May 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 22 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 22 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Feb 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 19 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Nov 2021 — NOTICE OF SUIT
- 05 May 2021 — NOTICE OF SUIT
- 27 Apr 2021 — NOTICE OF SUIT
- 21 May 2020 — COUNTERCLAIM OPP. NO. 999999
- 19 May 2020 — TEAS SECTION 8 & 15 RECEIVED